Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00755924 · ClinicalTrials.gov registry record · Phase 1

Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

A Phase 1 study, sponsored by HealthPartners Institute.

Completed
Registry status
Phase 1
Development phase
114
Enrollment target

NCT00755924: Completed Phase 1 study, sponsored by HealthPartners Institute.

NCT00755924 is a Phase 1 study that has completed, run by HealthPartners Institute. The registered enrollment target is 114 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00755924, a Phase 1 study, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
Phase 1
Development phase
114 participants
Enrollment target

Study Summary

This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Vinegar

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2008-06
Est. Completion 2010-07
Phase Phase 1
HealthPartners Institute

146 total trials

What the finished NCT00755924 record still lists

NCT00755924 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% higher).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00755924 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00755924 about?

NCT00755924 is a clinical study titled "Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein". This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline,...

What is the current status of trial NCT00755924?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 114 participants. The study started on 2008-06. Estimated completion is 2010-07.

What interventions are being tested in trial NCT00755924?

The interventions under investigation include: Placebo (OTHER), Vinegar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00755924?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00755924's enrollment target sits among peer trials

114 507th of 2000 higher than 1,493 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04522791 · 114 participants · Phase 2

    Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

  • NCT04875052 · 114 participants · NA

    Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

  • NCT05100342 · 114 participants

    Prospective Validation of a Points Score System Predicting 30-day Survival

  • NCT05224089 · 114 participants · Phase 4

    Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00755924, the US trial registry maintained by the National Library of Medicine. NCT00755924 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.